Ricardo Dolmetsch
Consultant / Advisor presso Trialspark, Inc.
Patrimonio netto: 849 701 $ in data 31/03/2024
Profilo
Ricardo Dolmetsch is currently an advisor at Formation Bio Inc. He previously worked as a Senior Director at The Allen Institute for Brain Science and as the Global Head-Neuroscience at Novartis Institutes for Biomedical Research, Inc. He will be the President & Chief Scientific Officer at uniQure NV from 2020 to 2023.
He also worked as a Professor at Stanford University School of Medicine.
Dolmetsch received his undergraduate degree from Brown University and his doctorate from Stanford University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
UNIQURE N.V.
0.34% | 18/09/2023 | 163 404 ( 0.34% ) | 849 701 $ | 31/03/2024 |
Posizioni attive di Ricardo Dolmetsch
Società | Posizione | Inizio |
---|---|---|
Trialspark, Inc.
Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Consultant / Advisor | - |
Precedenti posizioni note di Ricardo Dolmetsch
Società | Posizione | Fine |
---|---|---|
UNIQURE N.V. | President | 05/10/2023 |
The Allen Institute for Brain Science
The Allen Institute for Brain Science Miscellaneous Commercial ServicesCommercial Services The Allen Institute for Brain Science operates as a bioscience research organization, dedicated to accelerating research globally and sharing that data within the science community. The company was founded by Paul Gardner Allen and Jody Allen Patton in 2003 and is headquartered in Seattle, WA. | Director/Board Member | - |
Stanford University School of Medicine | Corporate Officer/Principal | - |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Ricardo Dolmetsch
Brown University | Undergraduate Degree |
Stanford University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
UNIQURE N.V. | Health Technology |
Aziende private | 3 |
---|---|
The Allen Institute for Brain Science
The Allen Institute for Brain Science Miscellaneous Commercial ServicesCommercial Services The Allen Institute for Brain Science operates as a bioscience research organization, dedicated to accelerating research globally and sharing that data within the science community. The company was founded by Paul Gardner Allen and Jody Allen Patton in 2003 and is headquartered in Seattle, WA. | Commercial Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Trialspark, Inc.
Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Finance |
- Borsa valori
- Insiders
- Ricardo Dolmetsch